PROGYNOVA

This brand name is authorized in Austria, Australia, Germany, Spain, Finland, France, Israel, Malta, Netherlands, New Zealand, Singapore, United Kingdom, South Africa

Active ingredients

The drug PROGYNOVA contains one active pharmaceutical ingredient (API):

1 Estradiol
UNII OKG364O896 - ESTRADIOL VALERATE

Estradiol, is chemically and biologically identical to endogenous human estradiol. It substitutes for the loss of oestrogen production in menopausal women, and alleviates menopausal symptoms. Oestrogens prevent bone loss following menopause or ovariectomy.

Read about Estradiol

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
PROGYNOVA 1mg Coated tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
PROGYNOVA Transdermal patch Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
PROGYNOVA 2mg Coated tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
G03CA03 Estradiol G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03C Estrogens → G03CA Natural and semisynthetic estrogens, plain
Discover more medicines within G03CA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: AU Pharmaceutical Benefits Scheme Identifier(s): 1663M, 1664N
Country: DE Bundesinstitut für Arzneimittel und Medizinprodukte Identifier(s): 01194070, 01316099, 01316107
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 14422, 47814
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 444844, 444851, 515148, 515155
Country: FR Base de données publique des médicaments Identifier(s): 60940721, 62512491
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 147289, 147291, 162274, 162276, 176256, 28455, 28462, 29401, 29508, 376990, 381643
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 4365
Country: MT Medicines Authority Identifier(s): AA1228/00701, AA565/38702
Country: NL Z-Index G-Standaard, PRK Identifier(s): 19518, 388
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 902, 903
Country: SG Health Sciences Authority Identifier(s): 04456P
Country: ZA Health Products Regulatory Authority Identifier(s): B/21.8.1/16

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.